Nonclinical findings provide evidence of the mechanism of action of nomlabofusp and support the potential use of skin FXN concentrations as a novel surrogate endpoint for Larimar’s planned BLA ...

Martin Marietta Materials, Inc. (NYSE: MLM) ('Martin Marietta” or the 'Company”), a leading national supplier of aggregates and heavy building materials, today announced the appointment of Michael J.